Eversept Partners’s Axogen AXGN Stock Holding History

Eversept Partners’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-57,723	Closed	-$1.63M	–	58
2017 Q4	$1.63M	Buy	+57,723	New	+$1.36M	0.94%	26

Other funds holding AXGN

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners's AXGN Position: Q1 2018 in Review

Eversept Partners sold out of Axogen (AXGN) in Q1 2018, closing a stake of 57,723 shares — an estimated $1.63M sold.

Eversept Partners first reported a position in AXGN in Q4 2017 and held it in 1 quarter. The position peaked at $1.63M in Q4 2017. 147 funds tracked by Wall St. Rank hold AXGN as of Q1 2018.

Eversept Partners reported no remaining Axogen position as of Q1 2018 after selling out during the quarter.
Eversept Partners sold 57,723 Axogen shares in Q1 2018, an estimated $1.63M.
Eversept Partners first reported a position in Axogen in Q4 2017 and held it in 1 quarter.
Eversept Partners's Axogen position peaked at $1.63M in Q4 2017.
147 funds tracked by Wall St. Rank held Axogen as of Q1 2018.

Based on Eversept Partners's 13F filing for Q1 2018, filed 14 May 2018.